BIOMARIN PHARMACEUTICAL INC

NASDAQ: BMRN (BioMarin Pharmaceutical Inc.)

Last update: 5 days ago, 10:13PM

54.13

-0.90 (-1.64%)

  • 1D -1.64%
  • 5D -5.75%
  • 1M -11.42%
  • 6M 0.52%
  • YTD -8.95%
  • 1Y -24.27%
  • 5Y -28.29%
Previous Close 55.03
Open 54.86
Volume 4,353,107
Avg. Volume (3M) 2,203,475
Market Cap 10,410,463,232
Price / Earnings (TTM) 30.07
Price / Earnings (Forward) 10.71
Price / Sales 3.32
Price / Book 1.71
52 Weeks Range
50.76 (-6%) — 73.18 (35%)
Earnings Date 30 Apr 2026
Profit Margin 17.76%
Operating Margin (TTM) 30.05%
Diluted EPS (TTM) 2.70
Quarterly Revenue Growth (YOY) 14.80%
Quarterly Earnings Growth (YOY) 109.40%
Total Debt/Equity (MRQ) 10.39%
Current Ratio (MRQ) 5.52
Operating Cash Flow (TTM) 700.26 M
Levered Free Cash Flow (TTM) 411.56 M
Return on Assets (TTM) 6.38%
Return on Equity (TTM) 9.64%

Market Trend

Short Term Medium Term
Industry Biotechnology (US) Bullish Mixed
Biotechnology (Global) Bullish Mixed
Stock BioMarin Pharmaceutical Inc. Bullish Bearish

AIStockmoo Score

0.0
Analyst Consensus 5.0
Insider Activity 2.0
Price Volatility -2.0
Technical Moving Averages -2.5
Technical Oscillators -2.5
Average 0.00

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
BMRN 10 B - 30.07 1.71
INSM 32 B - - 42.00
ONC 32 B - 111.23 7.01
WVE 1 B - - 4.27
VRTX 116 B - 29.68 6.10
INCY 18 B - 14.46 3.50

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.
Sector Healthcare
Industry Biotechnology
Investment Style Mid Growth
% Held by Insiders 0.77%
% Held by Institutions 98.91%
52 Weeks Range
50.76 (-6%) — 73.18 (35%)
Price Target Range
55.00 (1%) — 105.00 (93%)
High 105.00 (Barclays, 93.98%) Buy
Median 86.00 (58.88%)
Low 55.00 (HC Wainwright & Co., 1.61%) Hold
Average 87.00 (60.72%)
Total 8 Buy, 1 Hold
Avg. Price @ Call 60.78
Firm Date Target Price Call Price @ Call
B of A Securities 11 Mar 2026 85.00 (57.03%) Buy 60.32
Barclays 04 Mar 2026 105.00 (93.98%) Buy 60.43
HC Wainwright & Co. 02 Mar 2026 55.00 (1.61%) Hold 59.74
25 Feb 2026 55.00 (1.61%) Hold 61.44
Canaccord Genuity 26 Feb 2026 104.00 (92.13%) Buy 61.11
20 Jan 2026 98.00 (81.05%) Buy 56.31
Bernstein 25 Feb 2026 94.00 (73.66%) Buy 61.44
Guggenheim 25 Feb 2026 86.00 (58.88%) Buy 61.44
Oppenheimer 24 Feb 2026 95.00 (75.50%) Buy 62.62
Wells Fargo 18 Feb 2026 75.00 (38.56%) Buy 61.83
Piper Sandler 06 Feb 2026 84.00 (55.18%) Buy 58.13
Show more
Name Avg. Buy ($) Avg. Sell ($) Net Quantity Net Value ($)
DAVIS GEORGE ERIC 57.43 56.43 6,120 354,018
FRIBERG GREGORY R 57.43 56.05 17,521 1,008,479
GUYER CHARLES GREG 57.43 57.28 4,188 233,015
HARDY ALEXANDER 57.43 57.28 55,247 3,175,527
HUBBARD CRISTIN 57.43 56.05 14,165 815,214
MUELLER BRIAN 57.43 57.28 6,678 375,698
Aggregate Net Quantity 103,919
Aggregate Net Value ($) 5,961,951
Aggregate Avg. Buy ($) 57.43
Aggregate Avg. Sell ($) 56.86
Insider Range ($)
57.43 (6%) — 58.51 (8%)
Name Holder Date Type Quantity Price Value ($)
DAVIS GEORGE ERIC Officer 18 Mar 2026 Disposed (-) 1,273 55.43 70,562
FRIBERG GREGORY R Officer 17 Mar 2026 Disposed (-) 1,629 56.05 91,305
HUBBARD CRISTIN Officer 17 Mar 2026 Disposed (-) 1,245 56.05 69,782
HARDY ALEXANDER Officer 17 Mar 2026 Disposed (-) 4,252 56.05 238,325
MUELLER BRIAN Officer 17 Mar 2026 Disposed (-) 2,117 56.05 118,658
GUYER CHARLES GREG Officer 17 Mar 2026 Disposed (-) 1,693 56.05 94,893
HARDY ALEXANDER Officer 16 Mar 2026 Acquired (+) 62,440 57.43 3,585,929
MUELLER BRIAN Officer 16 Mar 2026 Acquired (+) 18,740 57.43 1,076,238
DAVIS GEORGE ERIC Officer 16 Mar 2026 Disposed (-) 7,177 57.43 412,175
DAVIS GEORGE ERIC Officer 16 Mar 2026 Acquired (+) 14,570 57.43 836,755
GUYER CHARLES GREG Officer 16 Mar 2026 Acquired (+) 14,990 57.43 860,876
FRIBERG GREGORY R Officer 16 Mar 2026 Acquired (+) 19,150 57.43 1,099,785
HUBBARD CRISTIN Officer 16 Mar 2026 Acquired (+) 15,410 57.43 884,996
HARDY ALEXANDER Officer 13 Mar 2026 Disposed (-) 2,941 58.51 172,078
MUELLER BRIAN Officer 13 Mar 2026 Disposed (-) 9,945 58.51 581,882
GUYER CHARLES GREG Officer 13 Mar 2026 Disposed (-) 9,109 58.51 532,968
Show more

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria